{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:54:40Z","timestamp":1791158080685,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,9,23]],"date-time":"2010-09-23T00:00:00Z","timestamp":1285200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,9,23]],"date-time":"2010-09-23T00:00:00Z","timestamp":1285200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1038\/leu.2010.201","type":"journal-article","created":{"date-parts":[[2010,9,23]],"date-time":"2010-09-23T10:08:17Z","timestamp":1285236497000},"page":"2063-2071","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Reduced expression of the tumor suppressor PHLPP1 enhances the antiapoptotic B-cell receptor signal in chronic lymphocytic leukemia B-cells"],"prefix":"10.1038","volume":"24","author":[{"given":"M","family":"Suljagic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Laurenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tarnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S N","family":"Malek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D G","family":"Efremov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,23]]},"reference":[{"key":"BFleu2010201_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1053\/j.seminhematol.2004.05.003","volume":"41","author":"M Ferrarini","year":"2004","unstructured":"Ferrarini M, Chiorazzi N . Recent advances in the molecular biology and immunobiology of chronic lymphocytic leukemia. Semin Hematol 2004; 41: 207\u2013223.","journal-title":"Semin Hematol"},{"key":"BFleu2010201_CR2","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1182\/blood-2003-12-4312","volume":"103","author":"FK Stevenson","year":"2004","unstructured":"Stevenson FK, Caligaris-Cappio F . Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood 2004; 103: 4389\u20134395.","journal-title":"Blood"},{"key":"BFleu2010201_CR3","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1182\/blood-2004-07-2669","volume":"105","author":"A Petlickovski","year":"2005","unstructured":"Petlickovski A, Laurenti L, Li X, Marietti S, Chiusolo P, Sica S et al. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B-cells. Blood 2005; 105: 4820\u20134827.","journal-title":"Blood"},{"key":"BFleu2010201_CR4","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1182\/blood-2007-05-089037","volume":"111","author":"PG Longo","year":"2008","unstructured":"Longo PG, Laurenti L, Gobessi S, Sica S, Leone G, Efremov DG . The Akt\/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells. Blood 2008; 111: 846\u2013855.","journal-title":"Blood"},{"key":"BFleu2010201_CR5","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1182\/blood-2009-03-208256","volume":"114","author":"M Herling","year":"2009","unstructured":"Herling M, Patel KA, Weit N, Lilienthal N, Hallek M, Keating MJ et al. High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia. Blood 2009; 114: 4675\u20134686.","journal-title":"Blood"},{"key":"BFleu2010201_CR6","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1182\/blood.V99.8.2969","volume":"99","author":"M Barrag\u00e1n","year":"2002","unstructured":"Barrag\u00e1n M, Bellosillo B, Camp\u00e0s C, Colomer D, Pons G, Gil J . Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells. Blood 2002; 99: 2969\u20132976.","journal-title":"Blood"},{"key":"BFleu2010201_CR7","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/sj.leu.2403398","volume":"18","author":"S Cun\u00ed","year":"2004","unstructured":"Cun\u00ed S, P\u00e9rez-Aciego P, P\u00e9rez-Chac\u00f3n G, Vargas JA, S\u00e1nchez A, Mart\u00edn-Saavedra FM et al. A sustained activation of PI3K\/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells. Leukemia 2004; 18: 1391\u20131400.","journal-title":"Leukemia"},{"key":"BFleu2010201_CR8","doi-asserted-by":"publisher","first-page":"9498","DOI":"10.1074\/jbc.M410455200","volume":"280","author":"X Hu","year":"2005","unstructured":"Hu X, Haney N, Kropp D, Kabore AF, Johnston JB, Gibson SB . Lysophosphatidic acid (LPA) protects primary chronic lymphocytic leukemia cells from apoptosis through LPA receptor activation of the anti-apoptotic protein AKT\/PKB. J Biol Chem 2005; 280: 9498\u20139508.","journal-title":"J Biol Chem"},{"key":"BFleu2010201_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/sj.leu.2404417","volume":"21","author":"PG Longo","year":"2007","unstructured":"Longo PG, Laurenti L, Gobessi S, Petlickovski A, Pelosi M, Chiusolo P et al. The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease. Leukemia 2007; 21: 110\u2013120.","journal-title":"Leukemia"},{"key":"BFleu2010201_CR10","doi-asserted-by":"publisher","first-page":"7081","DOI":"10.1038\/sj.onc.1210519","volume":"26","author":"M Ticchioni","year":"2007","unstructured":"Ticchioni M, Essafi M, Jeandel PY, Davi F, Cassuto JP, Deckert M et al. Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a. Oncogene 2007; 26: 7081\u20137091.","journal-title":"Oncogene"},{"key":"BFleu2010201_CR11","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.1182\/blood-2008-06-165068","volume":"113","author":"M Niedermeier","year":"2009","unstructured":"Niedermeier M, Hennessy BT, Knight ZA, Henneberg M, Hu J, Kurtova AV et al. Isoform-selective phosphoinositide 3\u2032-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach. Blood 2009; 113: 5549\u20135557.","journal-title":"Blood"},{"key":"BFleu2010201_CR12","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1038\/leu.2008.241","volume":"22","author":"JB Weinberg","year":"2008","unstructured":"Weinberg JB, Volkheimer AD, Mihovilovic M, Jiang N, Chen Y, Bond K et al. Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia. Leukemia 2008; 22: 2184\u20132192.","journal-title":"Leukemia"},{"key":"BFleu2010201_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1182\/blood-2008-02-138560","volume":"113","author":"K Balakrishnan","year":"2009","unstructured":"Balakrishnan K, Burger JA, Wierda WG, Gandhi V . AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance. Blood 2009; 113: 149\u2013153.","journal-title":"Blood"},{"key":"BFleu2010201_CR14","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.3324\/haematol.2008.004028","volume":"94","author":"M de Frias","year":"2009","unstructured":"de Frias M, Iglesias-Serret D, Cosialls AM, Coll-Mulet L, Santidri\u00e1n AF, Gonz\u00e1lez-Giron\u00e8s DM et al. Akt inhibitors induce apoptosis in chronic lymphocytic leukemia cells. Haematologica 2009; 94: 1698\u20131707.","journal-title":"Haematologica"},{"key":"BFleu2010201_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3324\/haematol.2009.010272","volume":"95","author":"J Zhuang","year":"2010","unstructured":"Zhuang J, Hawkins SF, Glenn MA, Lin K, Johnson GG, Carter A et al. Akt is activated in chronic-lymphocytic-leukemia cells and delivers a pro-survival signal: therapeutic potential of Akt inhibition. Haematologica 2010; 95: 110\u2013118.","journal-title":"Haematologica"},{"key":"BFleu2010201_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.tibs.2004.03.006","volume":"29","author":"DP Brazil","year":"2004","unstructured":"Brazil DP, Yang ZZ, Hemmings BA . Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem Sci 2004; 29: 233\u2013242.","journal-title":"Trends Biochem Sci"},{"key":"BFleu2010201_CR17","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","volume":"129","author":"BD Manning","year":"2007","unstructured":"Manning BD, Cantley LC . AKT\/PKB signaling: navigating downstream. Cell 2007; 129: 1261\u20131274.","journal-title":"Cell"},{"key":"BFleu2010201_CR18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0014-5793(99)01190-4","volume":"458","author":"K Shimizu","year":"1999","unstructured":"Shimizu K, Okada M, Takano A, Nagai K . SCOP, a novel gene product expressed in a circadian manner in rat suprachiasmatic nucleus. FEBS Lett 1999; 458: 363\u2013369.","journal-title":"FEBS Lett"},{"key":"BFleu2010201_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.molcel.2005.03.008","volume":"18","author":"T Gao","year":"2005","unstructured":"Gao T, Furnari F, Newton AC . PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 2005; 18: 13\u201324.","journal-title":"Mol Cell"},{"key":"BFleu2010201_CR20","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.molcel.2007.02.017","volume":"25","author":"J Brognard","year":"2007","unstructured":"Brognard J, Sierecki E, Gao T, Newton AC . PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol Cell 2007; 25: 917\u2013931.","journal-title":"Mol Cell"},{"key":"BFleu2010201_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.tem.2008.04.001","volume":"19","author":"J Brognard","year":"2008","unstructured":"Brognard J, Newton AC . PHLiPPing the switch on Akt and protein kinase C signaling. Trends Endocrinol Metab 2008; 19: 223\u2013230.","journal-title":"Trends Endocrinol Metab"},{"key":"BFleu2010201_CR22","doi-asserted-by":"publisher","first-page":"6300","DOI":"10.1074\/jbc.M707319200","volume":"283","author":"T Gao","year":"2008","unstructured":"Gao T, Brognard J, Newton AC . The phosphatase PHLPP controls the cellular levels of protein kinase C. J Biol Chem 2008; 283: 6300\u20136311.","journal-title":"J Biol Chem"},{"key":"BFleu2010201_CR23","doi-asserted-by":"publisher","first-page":"14920","DOI":"10.1074\/jbc.M213214200","volume":"278","author":"K Shimizu","year":"2003","unstructured":"Shimizu K, Okada M, Nagai K, Fukada Y . Suprachiasmatic nucleus circadian oscillatory protein, a novel binding partner of K-Ras in the membrane rafts, negatively regulates MAPK pathway. J Biol Chem 2003; 278: 14920\u201314925.","journal-title":"J Biol Chem"},{"key":"BFleu2010201_CR24","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/onc.2008.450","volume":"28","author":"J Liu","year":"2009","unstructured":"Liu J, Weiss HL, Rychahou P, Jackson LN, Evers BM, Gao T . Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis. Oncogene 2009; 28: 994\u20131004.","journal-title":"Oncogene"},{"key":"BFleu2010201_CR25","doi-asserted-by":"publisher","first-page":"5293","DOI":"10.1158\/0008-5472.CAN-07-0877","volume":"67","author":"M Qiao","year":"2007","unstructured":"Qiao M, Iglehart JD, Pardee AB . Metastatic potential of 21T human breast cancer cells depends on Akt\/protein kinase B activation. Cancer Res 2007; 67: 5293\u20135299.","journal-title":"Cancer Res"},{"key":"BFleu2010201_CR26","doi-asserted-by":"publisher","first-page":"22155","DOI":"10.1074\/jbc.M808182200","volume":"284","author":"I Hirano","year":"2009","unstructured":"Hirano I, Nakamura S, Yokota D, Ono T, Shigeno K, Fujisawa S et al. Depletion of Pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoforms. J Biol Chem 2009; 284: 22155\u201322165.","journal-title":"J Biol Chem"},{"key":"BFleu2010201_CR27","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1158\/0008-5472.CAN-07-3105","volume":"68","author":"P Ouillette","year":"2008","unstructured":"Ouillette P, Erba H, Kujawski L, Kaminski M, Shedden K, Malek SN . Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14. Cancer Res 2008; 68: 1012\u20131021.","journal-title":"Cancer Res"},{"key":"BFleu2010201_CR28","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1182\/blood-2008-03-146704","volume":"112","author":"DY Hallaert","year":"2008","unstructured":"Hallaert DY, Jaspers A, van Noesel CJ, van Oers MH, Kater AP, Eldering E . c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches. Blood 2008; 112: 5141\u20135149.","journal-title":"Blood"},{"key":"BFleu2010201_CR29","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.cell.2006.12.047","volume":"128","author":"K Shimizu","year":"2007","unstructured":"Shimizu K, Phan T, Mansuy IM, Storm DR . Proteolytic degradation of SCOP in the hippocampus contributes to activation of MAP kinase and memory. Cell 2007; 128: 1219\u20131229.","journal-title":"Cell"},{"key":"BFleu2010201_CR30","doi-asserted-by":"publisher","first-page":"6192","DOI":"10.1128\/MCB.00681-09","volume":"29","author":"X Li","year":"2009","unstructured":"Li X, Liu J, Gao T . {beta}-TrCP-mediated ubiquitination and degradation of PHLPP1 is negatively regulated by Akt. Mol Cell Biol 2009; 29: 6192\u20136205.","journal-title":"Mol Cell Biol"},{"key":"BFleu2010201_CR31","doi-asserted-by":"publisher","first-page":"5497","DOI":"10.1038\/onc.2008.245","volume":"27","author":"TL Yuan","year":"2008","unstructured":"Yuan TL, Cantley LC . PI3K pathway alterations in cancer: variations on a theme. Oncogene 2008; 27: 5497\u20135510.","journal-title":"Oncogene"},{"key":"BFleu2010201_CR32","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","volume":"275","author":"J Li","year":"1997","unstructured":"Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275: 1943\u20131947.","journal-title":"Science"},{"key":"BFleu2010201_CR33","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1126\/science.1096502","volume":"304","author":"Y Samuels","year":"2004","unstructured":"Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 2004; 304: 554.","journal-title":"Science"},{"key":"BFleu2010201_CR34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nature05933","volume":"448","author":"JD Carpten","year":"2007","unstructured":"Carpten JD, Faber AL, Horn C, Donoho GP, Briggs SL, Robbins CM et al. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 2007; 448: 439\u2013444.","journal-title":"Nature"},{"key":"BFleu2010201_CR35","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1365-2141.2008.07113.x","volume":"141","author":"T Zenz","year":"2008","unstructured":"Zenz T, D\u00f6hner K, Denzel T, D\u00f6hner H, Stilgenbauer S, Bullinger L . Chronic lymphocytic leukaemia and acute myeloid leukaemia are not associated with AKT1 pleckstrin homology domain (E17K) mutations. Br J Haematol 2008; 141: 742\u2013743.","journal-title":"Br J Haematol"},{"key":"BFleu2010201_CR36","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/sj.bjc.6604512","volume":"99","author":"IS Mahmoud","year":"2008","unstructured":"Mahmoud IS, Sughayer MA, Mohammad HA, Awidi AS, EL-Khateeb MS, Ismail SI . The transforming mutation E17K\/AKT1 is not a major event in B-cell-derived lymphoid leukaemias. Br J Cancer 2008; 99: 488\u2013490.","journal-title":"Br J Cancer"},{"key":"BFleu2010201_CR37","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1080\/10428190902803651","volume":"50","author":"M Marincevic","year":"2009","unstructured":"Marincevic M, Tobin G, Rosenquist R . Infrequent occurrence of PIK3CA mutations in chronic lymphocytic leukemia. Leuk Lymphoma 2009; 50: 829\u2013830.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2010201_CR38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1365-2141.2003.04227.x","volume":"121","author":"N Leupin","year":"2003","unstructured":"Leupin N, Cenni B, Novak U, H\u00fcgli B, Graber HU, Tobler A et al. Disparate expression of the PTEN gene: a novel finding in B-cell chronic lymphocytic leukaemia (B-CLL). Br J Haematol 2003; 121: 97\u2013100.","journal-title":"Br J Haematol"},{"key":"BFleu2010201_CR39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1182\/blood.V96.1.269","volume":"96","author":"P Masdehors","year":"2000","unstructured":"Masdehors P, Merle-B\u00e9ral H, Maloum K, Omura S, Magdel\u00e9nat H, Delic J . Deregulation of the ubiquitin system and p53 proteolysis modify the apoptotic response in B-CLL lymphocytes. Blood 2000; 96: 269\u2013274.","journal-title":"Blood"},{"key":"BFleu2010201_CR40","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1182\/blood-2001-11-0073","volume":"100","author":"JM Witkowski","year":"2002","unstructured":"Witkowski JM, Zmuda-Trzebiatowska E, Swiercz JM, Cichorek M, Ciepluch H, Lewandowski K et al. Modulation of the activity of calcium-activated neutral proteases (calpains) in chronic lymphocytic leukemia (B-CLL) cells. Blood 2002; 100: 1802\u20131809.","journal-title":"Blood"},{"key":"BFleu2010201_CR41","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1182\/blood-2007-10-110460","volume":"111","author":"SG Agrawal","year":"2008","unstructured":"Agrawal SG, Liu FT, Wiseman C, Shirali S, Liu H, Lillington D et al. Increased proteasomal degradation of Bax is a common feature of poor prognosis chronic lymphocytic leukemia. Blood 2008; 111: 2790\u20132796.","journal-title":"Blood"},{"key":"BFleu2010201_CR42","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1365-2796.2008.02030.x","volume":"264","author":"P Ghia","year":"2008","unstructured":"Ghia P, Chiorazzi N, Stamatopoulos K . Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation. J Intern Med 2008; 264: 549\u2013562.","journal-title":"J Intern Med"},{"key":"BFleu2010201_CR43","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1182\/blood.V86.3.1090.1090","volume":"86","author":"AC Lankester","year":"1995","unstructured":"Lankester AC, van Schijndel GM, van der Schoot CE, van Oers MH, van Noesel CJ, van Lier RA . Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells. Blood 1995; 86: 1090\u20131097.","journal-title":"Blood"},{"key":"BFleu2010201_CR44","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1182\/blood-2006-11-056648","volume":"109","author":"CI Mockridge","year":"2007","unstructured":"Mockridge CI, Potter KN, Wheatley I, Neville LA, Packham G, Stevenson FK . Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status. Blood 2007; 109: 4424\u20134431.","journal-title":"Blood"},{"key":"BFleu2010201_CR45","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1182\/blood-2006-03-011759","volume":"109","author":"S Gobessi","year":"2007","unstructured":"Gobessi S, Laurenti L, Longo PG, Sica S, Leone G, Efremov DG . ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells. Blood 2007; 109: 2032\u20132039.","journal-title":"Blood"},{"key":"BFleu2010201_CR46","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1182\/blood-2006-03-012021","volume":"109","author":"ST Abrams","year":"2007","unstructured":"Abrams ST, Lakum T, Lin K, Jones GM, Treweeke AT, Farahani M et al. B-cell receptor signaling in chronic lymphocytic leukemia cells is regulated by overexpressed active protein kinase CbetaII. Blood 2007; 109: 1193\u20131201.","journal-title":"Blood"},{"key":"BFleu2010201_CR47","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1182\/blood-2009-08-239244","volume":"115","author":"N Capitani","year":"2010","unstructured":"Capitani N, Lucherini OM, Sozzi E, Ferro M, Giommoni N, Finetti F et al. Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia. Blood 2010; 115: 3726\u20133736.","journal-title":"Blood"},{"key":"BFleu2010201_CR48","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1073\/pnas.102181599","volume":"99","author":"R Bichi","year":"2002","unstructured":"Bichi R, Shinton SA, Martin ES, Koval A, Calin GA, Cesari R et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci USA 2002; 99: 6955\u20136960.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2010201_CR49","doi-asserted-by":"publisher","first-page":"11713","DOI":"10.1073\/pnas.0604564103","volume":"103","author":"XJ Yan","year":"2006","unstructured":"Yan XJ, Albesiano E, Zanesi N, Yancopoulos S, Sawyer A, Romano E et al. B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2006; 103: 11713\u201311718.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2010201_CR50","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1073\/pnas.0910292107","volume":"107","author":"S Masubuchi","year":"2010","unstructured":"Masubuchi S, Gao T, O\u2019Neill A, Eckel-Mahan K, Newton AC, Sassone-Corsi P . Protein phosphatase PHLPP1 controls the light-induced resetting of the circadian clock. Proc Natl Acad Sci USA 2010; 107: 1642\u20131647.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2010201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2010201","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2010201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T13:30:51Z","timestamp":1648733451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2010201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,23]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["BFleu2010201"],"URL":"https:\/\/doi.org\/10.1038\/leu.2010.201","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,23]]},"assertion":[{"value":"18 December 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}